Real-World Outcomes of Dedicated Leaflet Modification for Bioprosthetic Valve-In-Valve TAVR: A 150-Patient Commercial Experience

Heart, Artery and Coronary DiseasesTherapy and Intervention
Do you want to read an article? Please log in or register.